HK1110529A1 - Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides - Google Patents

Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Info

Publication number
HK1110529A1
HK1110529A1 HK08105026.9A HK08105026A HK1110529A1 HK 1110529 A1 HK1110529 A1 HK 1110529A1 HK 08105026 A HK08105026 A HK 08105026A HK 1110529 A1 HK1110529 A1 HK 1110529A1
Authority
HK
Hong Kong
Prior art keywords
peptides
growth factor
vascular endothelial
factor receptor
endothelial growth
Prior art date
Application number
HK08105026.9A
Other languages
English (en)
Inventor
Hideaki Tahara
Takuya Tsunoda
Masabumi Shibuya
Shuichi Nakatsuru
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Priority to HK10101587.5A priority Critical patent/HK1133601A1/xx
Publication of HK1110529A1 publication Critical patent/HK1110529A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
HK08105026.9A 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides HK1110529A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK10101587.5A HK1133601A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65752705P 2005-02-28 2005-02-28
PCT/JP2006/303352 WO2006093030A1 (en) 2005-02-28 2006-02-17 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Publications (1)

Publication Number Publication Date
HK1110529A1 true HK1110529A1 (en) 2008-07-18

Family

ID=36581423

Family Applications (3)

Application Number Title Priority Date Filing Date
HK08105026.9A HK1110529A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
HK10101587.5A HK1133601A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
HK11106949.6A HK1152873A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK10101587.5A HK1133601A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
HK11106949.6A HK1152873A1 (en) 2005-02-28 2008-05-06 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Country Status (11)

Country Link
US (4) US7919099B2 (pt)
EP (4) EP2095822B1 (pt)
JP (3) JP4931154B2 (pt)
CY (1) CY1112867T1 (pt)
DK (3) DK2095822T3 (pt)
ES (3) ES2435650T3 (pt)
HK (3) HK1110529A1 (pt)
PL (3) PL1855707T3 (pt)
PT (3) PT2095822E (pt)
SI (3) SI2289533T1 (pt)
WO (1) WO2006093030A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2267021B1 (en) * 2002-09-12 2015-02-18 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
MX2009008750A (es) * 2007-02-16 2009-08-27 Oncotherapy Science Inc Terapia de vacuna para neovascularizacion coroidal.
TW201109029A (en) * 2009-06-11 2011-03-16 Oncotherapy Science Inc Vaccine therapy for choroidal neovascularization
SG11201405578TA (en) 2012-03-09 2014-11-27 Oncotherapy Science Inc Pharmaceutical composition containing peptide
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
RU2744860C2 (ru) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Антитела и их конъюгаты
JP7168228B2 (ja) * 2017-05-19 2022-11-09 慶應義塾 脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物
WO2019169341A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CN114786731A (zh) 2019-10-10 2022-07-22 科达制药股份有限公司 治疗眼部病症的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
JPH0418667A (ja) * 1989-07-05 1992-01-22 Tohoku Nippon Denki Software Kk 自動配送システム
JPH0350140A (ja) * 1989-07-18 1991-03-04 Seiko Epson Corp 分布屈折率レンズの製造方法
DK0694042T3 (da) * 1993-03-25 2005-02-14 Merck & Co Inc Inhibitor af vaskulær endothelcellevækstfaktor
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
CA2225553A1 (en) 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US6100071A (en) * 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6200954B1 (en) * 1998-09-04 2001-03-13 National University Of Singapore Small peptides having potent anti-angiogenic activity
WO2002072627A2 (en) * 2001-03-09 2002-09-19 Callistogen Ag Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
FI110549B (fi) 2001-06-29 2003-02-14 Nokia Corp Menetelmä ja järjestely liikkeen määrittämiseksi
US20030157101A1 (en) 2001-11-15 2003-08-21 Carlo Gambacorti-Passerini Immunogenic ALK peptides
US20050130899A1 (en) 2001-12-10 2005-06-16 Kyogo Itoh Tumor antigens
CU23178A1 (es) * 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
JP2004018667A (ja) 2002-06-17 2004-01-22 National Institute Of Advanced Industrial & Technology 高分子化合物膜の表面における炭酸カルシウム被膜の製造方法
JP4406607B2 (ja) 2002-08-26 2010-02-03 オンコセラピー・サイエンス株式会社 ペプチド及びこれを含む医薬
EP2267021B1 (en) * 2002-09-12 2015-02-18 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
TW201109029A (en) 2009-06-11 2011-03-16 Oncotherapy Science Inc Vaccine therapy for choroidal neovascularization

Also Published As

Publication number Publication date
SI1855707T1 (sl) 2012-07-31
EP2289533B1 (en) 2013-09-18
PL2095822T3 (pl) 2014-03-31
CY1112867T1 (el) 2016-04-13
EP2289532A1 (en) 2011-03-02
US20090214581A1 (en) 2009-08-27
JP2008531463A (ja) 2008-08-14
PT2289533E (pt) 2013-12-10
PL2289533T3 (pl) 2014-02-28
US7919099B2 (en) 2011-04-05
HK1152873A1 (en) 2012-03-16
US20110250219A1 (en) 2011-10-13
US8663647B2 (en) 2014-03-04
US20140186381A1 (en) 2014-07-03
JP2010265269A (ja) 2010-11-25
HK1133601A1 (en) 2010-04-01
JP4843095B2 (ja) 2011-12-21
EP2095822A1 (en) 2009-09-02
DK2095822T3 (da) 2014-01-13
ES2385396T3 (es) 2012-07-24
EP1855707B1 (en) 2012-04-04
JP2012102105A (ja) 2012-05-31
US20120294877A1 (en) 2012-11-22
US8257711B2 (en) 2012-09-04
DK1855707T3 (da) 2012-07-16
PL1855707T3 (pl) 2012-08-31
SI2289533T1 (sl) 2013-11-29
PT2095822E (pt) 2013-12-09
DK2289533T3 (da) 2013-12-02
ES2442294T3 (es) 2014-02-11
ES2435650T3 (es) 2013-12-20
EP2095822B1 (en) 2013-10-16
EP2289533A1 (en) 2011-03-02
JP4931154B2 (ja) 2012-05-16
JP5789820B2 (ja) 2015-10-07
SI2095822T1 (sl) 2013-12-31
PT1855707E (pt) 2012-05-25
EP1855707A1 (en) 2007-11-21
WO2006093030A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
HK1110529A1 (en) Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
HK1167325A1 (en) Antibodies against vascular endothelial growth factor receptor-1 -1
EP1699484A4 (en) HUMANIZED ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR
IL178070A (en) Antibiotic p-selectin antibodies and pharmaceuticals that include them
IL186959A0 (en) Peptides and pharmaceutical compositions containing the same
IL230645A (en) Antibodies against activin a or b and their use to promote bone growth
PL2272873T3 (pl) Przeciwciała przeciw receptorowi insulinopodobnego czynnika wzrostu I i ich zastosowania
IL187317A0 (en) A polypeptide complex and pharmaceutical compositions containing the same
IL182267A0 (en) Novel anthranilamide pyridinureas as vascular endothelial growth factor
PL1838341T3 (pl) Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę
EP2303912A4 (en) CDCA1-EPITOP-PEPTIDES AND VACCINES CONTAINING THEM
EP1948676A4 (en) CONJUGATE BASED ON BLOOD PROTEIN AND BIOACTIVE SUBSTANCE
ZA200708905B (en) Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
EP1893233A4 (en) PEPTIDES AND THERAPEUTIC VACCINES
EP1760098A4 (en) BIOCOMPATIBLE MATERIAL
HK1156341A1 (zh) 表位肽及包含它的疫苗
IL212046A0 (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
GB2417482B (en) Box or container support
ZA200800566B (en) Therapeutic peptides and vaccines
EP1881843A4 (en) KINASEPEPTIDES AND ANTIBODIES
GB0505093D0 (en) Tiana's bottle shaker
GB2425450B (en) Plant and container support
GB0418390D0 (en) Pot handler & cane support
GB0402179D0 (en) Bioactive peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160217